Also, Malakar et al. have indicated that MALAT1 promotes hepatocellular carcinoma development by serine/arginine-rich splicing factor 1 (SRSF1) upregulation and mammalian target of rapamycin (mTOR) activation [11]. This evidence concerns the gene SRSF1 and hepatocellular carcinoma.